Back to Trials
NCT05619900Recruiting

Registry of Patients Diagnosed With Lysosomal Storage Diseases

University of California, San Francisco

Start Date

5/31/2022

Completion Date

5/31/2050

Summary

This is an international prospective and retrospective registry of patients with Lysosomal Storage Diseases (LSDs) to understand the natural history of the disease and the outcomes of fetal therapies, with the overall goal of improving the prenatal management of patients with LSDs.

Detailed Description

The need for methods to track patient outcomes, clinical management, medical decision making, and quality of care are all part of current national mandates in patient safety and quality of care delivery. The aim of this registry is to prospectively and retrospectively collect data on patients who are diagnosed with Lysosomal Storage Disease and other LSD mutations. Data collected will be used to: 1. Identify patient outcomes of therapies. 2. Improve clinical management of patients with LSDs. 3. Improve medical decision making. 4. Improve quality of care.

Eligibility Criteria

Age Range: No minimum to 64 years

Inclusion Criteria: * Patients aged 0-64 with a diagnosis of a lysosomal storage disease * Pregnant patients whose fetus has a diagnosis of a lysosomal storage disease Exclusion Criteria: * There are no current exclusion criteria

Interventions

OTHER

There is no intervention

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Mucopolysaccharidosis IMucopolysaccharidosis IIMucopolysaccharidosis IV AMucopolysaccharidosis VIMucopolysaccharidosis VIIPompe Disease Infantile-OnsetNeuronopathic Gaucher DiseaseWolman Disease

Locations

University of California San Francisco

San Francisco, California 94143

United States